ChromaCode’s tech to boost COVID-19 testing gets Bill Gates backing

Boasting a technology that can dramatically increase the capacity of existing polymerase chain reaction (PCR) testing used to identify people infected with COVID-19 and other illnesses, ChromaCode has attracted new funding from Bill Gates-backed Adjuvant Capital.  “We want a good solution for a resource-limited environment,” says ChromaCode founder and executive chairman Alex Wilkinson, a serial entrepreneur […]

Read more